![Loading...](/modules/owl-carousel-widgets/img/ajax-loader.gif)
![home banner](https://www.iraspen.org/uploads/attachments/cls0dcrhc00znac91ih7p3tc9-home-banner.two-thirds.png)
![home banner 2](https://www.iraspen.org/uploads/attachments/cls0dgt9p015vac913hejys8v-home-banner-2.two-thirds.png)
![home banner 3](https://www.iraspen.org/uploads/attachments/cls0dh56t017hac91iikb0yao-home-banner-3.two-thirds.png)
![home banner 4](https://www.iraspen.org/uploads/attachments/cls0dhi0v0190ac913mutga8c-home-banner-4.two-thirds.png)
![home banner 5](https://www.iraspen.org/uploads/attachments/cls0dhtdl01agac91lr7r9775-home-banner-5.two-thirds.png)
Welcome to the IRASPEN Registry.
The International Rare And Severe Psoriasis Expert Network (IRASPEN). A Prospective Registry With Genotype-Phenotype Correlation. IRASPEN has arisen from the European ERASPEN registry that sought to harmonize the phenotypic descriptions and diagnostic criteria. Now we are looking for longitudinal follow-up data, more detailed clinical information including treatment response data, as well as biological samples and biomarkers we can measure and correlate with clinical outcomes.
The registry data should lead to a better understanding of pustular psoriasis with the ultimate aim of improved patient care.